P53 is a key regulator for osthole-triggered cancer pathogenesis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Huang, Ssu Ming ^a,b,c   Tsai, Cheng Fang ^d   Chen, Dar Ren ^e   Wang, Min Ying ^a   Yeh, Wei Lan ^e  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Division of Cardiology   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

OSTHOLE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; COUMARIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; TP53 PROTEIN, HUMAN;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL DEATH; CELL MOTILITY; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HCT116 CELL LINE; METABOLISM;

APOPTOSIS; CELL PROLIFERATION; COUMARINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MAP KINASE KINASE 4; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903555081     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/175247     Document Type: Article

References (44)

1. Friend S., p53: a glimpse at the puppet behind the shadow play. Science 1994 265 5170 334 335 2-s2.0-0028137084 (Pubitemid 24259956)
2. Levine A. J., p53, the cellular gatekeeper for growth and division. Cell 1997 88 3 323 331 2-s2.0-0030941458 10.1016/S0092-8674(00)81871-1 (Pubitemid 27131374)
3. Knappskog S., Lønning P. E., P53 and its molecular basis to chemoresistance in breast cancer. Expert Opinion on Therapeutic Targets 2012 16 supplement 1 S23 S30 2-s2.0-84857604395 10.1517/14728222.2011.640322
4. Livingstone L. R., White A., Sprouse J., Livanos E., Jacks T., Tisty T. D., Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992 70 6 923 935 2-s2.0-0026801062 10.1016/0092-8674(92) 90243-6
5. Ko L. J., Prives C., p53: puzzle and paradigm. Genes and Development 1996 10 9 1054 1072 2-s2.0-0029972806 (Pubitemid 26152848)
6. Garrington T. P., Johnson G. L., Organization and regulation of mitogen-activated protein kinase signaling pathways. Current Opinion in Cell Biology 1999 11 2 211 218 2-s2.0-0032910168 10.1016/S0955-0674(99)80028-3 (Pubitemid 29164036)
7. Mamay C. L., Mingo-Sion A. M., Wolf D. M., Molina M. D., Van Den Berg C. L., An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer. Oncogene 2003 22 4 602 614 2-s2.0-0037473115 10.1038/sj.onc. 1206186 (Pubitemid 36188617)
8. Liu H., Liang S.-L., Kumar S., Weyman C. M., Liu W., Zhou A., Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemotherapy and Pharmacology 2009 63 6 997 1005 2-s2.0-63949084962 10.1007/s00280-008-0830-7
9. Gupta S., Campbell D., Derijard B., Davis R. J., Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995 267 5196 389 393 2-s2.0-0028905076
10. Ham Y.-M., Choi J.-S., Chun K.-H., Joo S.-H., Lee S.-K., The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis. Journal of Biological Chemistry 2003 278 50 50330 50337 2-s2.0-0348010361 10.1074/jbc.M302997200 (Pubitemid 37548875)
11. Dinicola S., Pasqualato A., Cucina A., Coluccia P., Ferranti F., Canipari R., Catizone A., Proietti S., D'Anselmi F., Ricci G., Palombo A., Bizzarri M., Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion. European Journal of Nutrition 2014 53 2 421 431 2-s2.0-84878662046 10.1007/s00394-013-0542-6
12. Yin M.-C., Development of natural antitumor agents. BioMedicine 2013 3 3, article 105 2-s2.0-84881371513 10.1016/j.biomed.2013.06.001
13. Sadraei H., Shokoohinia Y., Sajjadi S. E., Mozafari M., Antispasmodic effects of Prangos ferulacea acetone extract and its main component osthole on ileum contraction. Research in Pharmaceutical Sciences 2013 8 2 137 144 2-s2.0-84873357270
14. Liu J., Zhang W., Zhou L., Wang X., Lian Q., Anti-inflammatory effect and mechanism of osthole in rats. Zhong Yao Cai 2005 28 11 1002 1006 2-s2.0-33748864602
15. Zhang Q., Qin L., He W., Van Puyvelde L., Maes D., Adams A., Zheng H., De Kimpe N., Coumarins from Cnidium monnieri and their antiosteoporotic activity. Planta Medica 2007 73 1 13 19 2-s2.0-33847794096 10.1055/s-2006-951724 (Pubitemid 46909846)
16. Luszczki J. J., Andres-Mach M., Cisowski W., Mazol I., Glowniak K., Czuczwar S. J., Osthole suppresses seizures in the mouse maximal electroshock seizure model. European Journal of Pharmacology 2009 607 1-3 107 109 2-s2.0-62149147196 10.1016/j.ejphar.2009.02.022
17. Xu X., Zhang Y., Qu D., Jiang T., Li S., Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. Journal of Experimental and Clinical Cancer Research 2011 30 1, article 33 2-s2.0-79953084520 10.1186/1756-9966-30-33
18. Riviere C., Goossens L., Pommery N., Fourneau C., Delelis A., Henichart J. P., Antiproliferative effects of isopentenylated coumarins isolated from Phellolophium madagascariense Baker. Natural Product Research 2006 20 10 909 916 2-s2.0-33746598575 10.1080/14786410500277787 (Pubitemid 44144701)
19. Chou S.-Y., Hsu C.-S., Wang K.-T., Wang M.-C., Wang C.-C., Antitumor effects of osthol from Cnidium monnieri: an in vitro and in vivo study. Phytotherapy Research 2007 21 3 226 230 2-s2.0-33947581715 10.1002/ptr.2044 (Pubitemid 46479671)
20. Kamata H., Hirata H., Redox regulation of cellular signalling. Cellular Signalling 1999 11 1 1 14 2-s2.0-0032889677 10.1016/S0898-6568(98)00037-0 (Pubitemid 28546635)
21. Annunziato L., Amoroso S., Pannaccione A., Cataldi M., Pignataro G., D'Alessio A., Sirabella R., Secondo A., Sibaud L., Di Renzo G. F., Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicology Letters 2003 139 2-3 125 133 2-s2.0-0037418621 10.1016/S0378-4274(02)00427-7 (Pubitemid 36298971)
22. Monks T. J., Xie R., Tikoo K., Lau S. S., Ros-induced histone modifications and their role in cell survival and cell death. Drug Metabolism Reviews 2006 38 4 755 767 2-s2.0-33845451723 10.1080/03602530600959649 (Pubitemid 44903267)
23. Mo L. Q., Chen Y., Song L., Wu G. M., Tang N., Zhang Y. Y., Wang X. B., Liu K. X., Zhou J., Osthole prevents intestinal ischemia-reperfusion-induced lung injury in a rodent model. Journal of Surgical Research 2014 189 2 285 294 10.1016/j.jss.2014.03.026
24. Zhou Y.-F., Li L., Feng F., Yuan H., Gao D.-K., Fu L.-A., Fei Z., Osthole attenuates spinal cord ischemia-reperfusion injury through mitochondrial biogenesis-independent inhibition of mitochondrial dysfunction in rats. Journal of Surgical Research 2013 185 2 805 814 2-s2.0-84880411712 10.1016/j.jss.2013. 06.044
25. Huang S.-M., Cheung C.-W., Chang C.-S., Tang C.-H., Liu J.-F., Lin Y.-H., Chen J.-H., Ko S.-H., Wong K.-L., Lu D.-Y., Phloroglucinol derivative MCPP induces cell apoptosis in human colon cancer. Journal of Cellular Biochemistry 2011 112 2 643 652 2-s2.0-79251629978 10.1002/jcb.22966
26. Huang S. M., Chen T. S., Chiu C. M., Chang L. K., Liao K. F., Tan H. M., Yeh W. L., Chang G. R., Wang M. Y., Lu D. Y., GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. Endocrine-Related Cancer 2013 21 1 73 84
27. Lu D.-Y., Chang C.-S., Yeh W.-L., Tang C.-H., Cheung C.-W., Leung Y.-M., Liu J.-F., Wong K.-L., The novel phloroglucinol derivative BFP induces apoptosis of glioma cancer through reactive oxygen species and endoplasmic reticulum stress pathways. Phytomedicine 2012 19 12 1093 1100 2-s2.0-84866415246 10.1016/j.phymed.2012.06.010
28. Tsai C.-F., Yeh W.-L., Huang S. M., Tan T.-W., Lu D.-Y., Wogonin induces reactive oxygen species production and cell apoptosis in human Glioma cancer cells. International Journal of Molecular Sciences 2012 13 8 9877 9892 2-s2.0-84864989279 10.3390/ijms13089877
29. Chen J.-H., Huang S.-M., Tan T.-W., Lin H.-Y., Chen P.-Y., Yeh W.-L., Chou S.-C., Tsai C.-F., Wei I.-H., Lu D.-Y., Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. International Immunopharmacology 2012 12 1 94 100 2-s2.0-84856110886 10.1016/j.intimp.2011.10.019
30. Lu D.-Y., Yeh W.-L., Huang S.-M., Tang C.-H., Lin H.-Y., Chou S.-J., Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro-Oncology 2012 14 11 1367 1378 2-s2.0-84868022009 10.1093/neuonc/nos262
31. Huang B. R., Chang P. C., Yeh W. L., Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLoS ONE 2014 9 3 e91167 10.1371/journal.pone.0091167
32. Lu D.-Y., Huang B.-R., Yeh W.-L., Lin H.-Y., Huang S.-S., Liu Y.-S., Kuo Y.-H., Anti-neuroinflammatory effect of a novel caffeamide derivative, KS370G, in microglial cells. Molecular Neurobiology 2013 1 12 2-s2.0-84879200383 10.1007/s12035-013-8474-y
33. Lu D.-Y., Chen J.-H., Tan T.-W., Huang C.-Y., Yeh W.-L., Hsu H.-C., Resistin protects against 6-hydroxydopamine-induced cell death in dopaminergic-like MES23.5 cells. Journal of Cellular Physiology 2013 228 3 563 571 2-s2.0-84870414226 10.1002/jcp.24163
34. 2+ store-depleted rat insulinoma RINm5F cells. BioMedicine 2013 3 3 130 139 2-s2.0-84881370670 10.1016/j.biomed.2012.11.003
35. Lin H.-Y., Yeh W.-L., Huang B.-R., Lin C., Lai C.-H., Lin H., Lu D.-Y., Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons. PLoS ONE 2012 7 11 2-s2.0-84870260248 10.1371/journal.pone.0050138 e50138
36. Saloustros E., Mavroudis D., Georgoulias V., Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opinion on Pharmacotherapy 2008 9 15 2603 2616 2-s2.0-55249122507 10.1517/14656566.9.15.2603
37. Tsai C. F., Yeh W. L., Chen J. H., Lin C., Huang S. S., Lu D. Y., Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression. International Journal of Molecular Sciences 2014 15 3 3889 3903
38. Selivanova G., Therapeutic targeting of p53 by small molecules. Seminars in Cancer Biology 2010 20 1 46 56 2-s2.0-77952543382 10.1016/j.semcancer.2010. 02.006
39. Junttila M. R., Karnezis A. N., Garcia D., Madriles F., Kortlever R. M., Rostker F., Brown Swigart L., Pham D. M., Seo Y., Evan G. I., Martins C. P., Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature 2010 468 7323 567 571 2-s2.0-78649492693 10.1038/nature09526
40. Feldser D. M., Kostova K. K., Winslow M. M., Taylor S. E., Cashman C., Whittaker C. A., Sanchez-Rivera F. J., Resnick R., Bronson R., Hemann M. T., Jacks T., Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature 2010 468 7323 572 575 2-s2.0-78649491016 10.1038/nature09535
41. Vousden K. H., Prives C., Blinded by the light: the growing complexity of p53. Cell 2009 137 3 413 431 2-s2.0-65349103899 10.1016/j.cell.2009.04.037
42. Jackson J. G., Pant V., Li Q., Chang L. L., Quintás-Cardama A., Garza D., Tavana O., Yang P., Manshouri T., Li Y., El-Naggar A. K., Lozano G., P53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 2012 21 6 793 806 2-s2.0-84862124987 10.1016/j.ccr.2012.04.027
43. Fukumura H., Sato M., Kezuka K., Sato I., Feng X., Okumura S., Fujita T., Yokoyama U., Eguchi H., Ishikawa Y., Saito T., Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. Journal of Physiological Sciences 2012 62 3 251 257 2-s2.0-84860727322 10.1007/s12576-012-0204-0
44. Roos W. P., Kaina B., DNA damage-induced cell death by apoptosis. Trends in Molecular Medicine 2006 12 9 440 450 2-s2.0-33747884339 10.1016/j.molmed. 2006.07.007 (Pubitemid 44291571)